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CGRP is a neuropeptide that has previously been 
described to possess inununosuppressive activities. 
CGRP is released from peripheral nerves that, in the 
skin, are in close physical association with dendritic 
APC. We sought to investigate the mechanisms by 
which CGRP can inhibit immune responses by study-
ing its effects on hUlnan peripheral blood Ulononu-
clear cells (PBMC). Using allogeneic monocytes as 
stimulator cells, CGRP could inhibit thc proliferation 
of PBMC by 47%, when CGRP was present for the 
duration of culture. Interestingly, when thc stin"lula-
tor U"lonocytes were incubatcd with CGRP for 2 h 
prior to irradiation then washed, the observ ed inhi-
bition increased to 85%, suggesting that CGRP was 
exerting a direct effcct on the monocyte stimulator 
population. Finally, the recall response to tetanus 
to~oid (TT) by PBMC from individuals vaccinated 
R ece nt evidellce sugges ts a close associa tio n be-twee n the Il e rvous and immulle system s (Paya ll and Goetzl. 1988 ; R.e ichlin. 1993 ) . Several Il eu-ropeptid es . illcludin g substance P. Il e uro kinill A. calc itonin . pro la c tin , seroto llin. vasoactive inresti-
n a l peptide. and th yro id-re leasillg ho rmo n e . hav e heell sh o wn to 
exert e ffects o n cells o f the iml1lun e syste m (Sirin ek and O ' Dorisi o 
1991 ; Umeda. 1992; J o rgensell and San y. 1994) . III addi tio n. 
several pro -inA aml1lato ry cytokines pro du ced b y th e immune sys-
te m h~ve dem o nstra ted ~ctivity in the dowllregulati o n of ne u-
l'opeptide-induced secre tion o f pro lac tin by the pituitary g land 
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Abbrevia tioll s: CG IU'. calci tonill -gene related pepride; PBM C. periph-
eral blood Ill oll olluclear ce ll s: APC. amige ll prcsellring cell: PI3L. peripheral 
blood lymphocytes; SAC, Sta phylococcus Ameus Cowans srrain I; TT. 
te tanus toxoid. 
with TT 14 d prior was inhibited by 25-50%, in the 
presence of CGRP. Also, CGRP decreased the l evels 
of B7.2 but not B7.1 on treated monocytes, and this 
inhibition could be abrogated by the addition of 
anti-IL-10 antibody, suggesting that the inhibition 
was Inediated by an increase in IL-10 production. 
Moreover, increased IL-10 production was confirmed 
by ELISA. Both IL-12 p40 and IFN-l' levels in CGRP-
treated cultures were found to be decreased b y ap-
proximat ely 30°/.,. The decrease in IL-12 p40 levels 
could be rev ersed by addition of anti-IL-10. These 
data suggest that CGRP inhibits PBMC proliferation, 
in part, through the rele asc of IL-10, which in t urn 
can downregulate important co-stimulatory Inole -
cules and the cytokincs IL-12 and IFN-l'. K eYIVO/'ds: 
ill"" II "OS II PIJl·cssio"/IIClIl'Opeptidcs/C)'tokillcs. ] I,,,,es t D e/,-
",ntol 1 ()8:43- 48, 1997 
nervo us systems is indi cated histologicall y by an intimate ph ysica l 
associatio n be tween n euron al fibers and antigen presen tin g ce ll s 
(A PC ) in the gastric mucos ~ Oakab 1'1 ai, 1993) an d in th e skin 
(Hoso i ('I ai, 1993). Furtherm ore, recepro rs fo r n euro peptides such 
as calci to nin gen e-re lated peptide (CGJUJ) o n he m o po ietic ce ll s 
(Abe llo Ci al. 199 1; M cG illis 1'1 a/1 99 1; Vi gn ery l'I al . 199 1; M cGillis 
l'I al 1993) and Langerh am cells (Asahin a CI al. 1995a . 1995b) 
indicare th at specifi c comlllunica tio ll path w ays exist between the 
two systems. 
CG RP is a 37-amino acid ne uro pep tid e derived from th e calci-
rOllin l G RP gene by altern ati ve RNA spli cin g (Am ara CI al.1 982) . 
which h~s potent va sodil a to ry pro perties (B rain ('I ai, 1985). In 
animal m od els it is an inhibiro r of mi togen- indu ced pe"i p heral 
blood m o no nu clear cells (PI3M e ) pro life rati ve and d ifFeren tiative 
respon ses (M cG illis el ai, 1993 ) . of inte rfero n-y (I FN -y)- indu ced 
pero xide fo rmatio n by m acrophages (Non g el al. 1989) . IL-2 
pro dn ctio n by lymphocytes (Wa ng e( al. 1992, 1995) as well as 
dela yed-type and conta ct hypersensit ivity (Asa hin a el nl. 1995a) . 
Finall y, ex posure of m acropha gcs o r Langerh ans cells to CG R.P i/l 
"ilm leads ro diminished antigen-presentin g capabili ty (Nong CI al. 
'1989 : ,Hoso i at ai, 1993 ; Asa hina CI al. 1995b). In n onn al hU11l~n 
indi viduals, CG RP is presenr in the se rU111 ar low levels (4 - 100 pM) 
but. is tound to be elevated ill several condi tio ns slI ch as th yro id 
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ca rci nollla , c1LJ.~ter h ea daches, and ac u te unoi ffe r e nti ated a nd acute 
Ill yel o bbsri c kukelllia (Tak:lIni anolw, I ~<)2; Wi m a la w:t n s:t, 1993; 
I<ider (' I (1 /1 994; Fanciu llacci ('/ (1 /,1 9<)5), 
IlI1nllllW re '~ flonses arc ini tiated b y the presentation o fa particu la r 
antigen (AV;) to immun e effector cd Is in rh e con text of:l pp ropriate 
major histocomp:ltibi li ty cOl1lp lex (MHC) rnokeu\es. In ;Iddit io n to 
t h e T-ce ll antigen receptor , seve ra l co-s tilllLJ latory m o lecules have 
been id entifi e d on both A PC and resp o ndin g T ce ll s. T hese 
molecules, C DHO (137. 1/ 1313 I ) ,md CD8(, (137.2), a r c liga nds for 
C D 28, whic h is present o n T cell s ( rev iewed in Linsley ri lld 
Ledbette r, 1993), and appear to play in tegr al roles in development 
of a competent immune response . T h e in te ractio n s of these co-
srimu latnry m olecul es a n d th e ir precise effects on t h e differen t iation 
or spcc ifi c immulle respo lHes a r c just now being elucidated (F ree-
Il1 a n ('/ ,,/, 1995: Kuch ruo t'l n/, 1<)95). 
JL-I () and IL- 12, two cytokil1es w ith poten t ill'1l11l1noregu la tory 
activ ity, ,Ire antagonisti c towa rd each oth e r (IYAndrea 1'1 (1/, 1993). 
IL-12 can preferentia ll y drive a developing illll1lune respon se 
toward a Til l (ce ll -mediated) illlnllll1c response. IL- I (l h as t h e 
ability to ab rogate this T hl- pro m oti n g nctioll . In addition, IL- ,){ ) ca n 
regu l;)\'c t h e expression oC U7 11l0 le c ules o n t h e slId; lce or APC 
(Ding c ( rT/, 11)1)3). T h e determi nant oj' which cytokine activ ity 
pre dol11inatcs is depe n dent o n t h e loca l concentration or each 
cytokin e .md /or rile t;]rgct cell 1Ipo n w hic h it is de ring. 
T h e llIechanism b y w hic h CG RP inhibits antigen presentatiOIl is 
nor cOlll p letely u nde rstood. CG Il,J) inhibi ts t h e UpI' 'gul ation of 
13 7.2 0 11 llIurillc peri ton ea l mac rophages li nd La ngerhans ce ll s 
(Asa hina ('I nl. I ()1)5;1, 1 ()95b) , although little is k n <lwn ahollt its 
m ech a lli s m of action .in human s. We dcmollStrate that CGRV can 
inhibit proliferative rcspollScs or P13MC to mitogellic a nd anl'igelli c 
sig lla ls. This elfect appears to b e mediated. in part, thr01lg h t h e 
e levatio n of I L- IO production by periph era l bl ood mon ocytes. 
h lrt h el'lnorc, t h e CG R.P-llledi"ted in c r" asc ill I L-l () downregula\'cs 
the cxpression or 137 molec ules , w hi c h, in turn , can decrease the 
abi li ty or [he 1Il01l0cyl:e to act as a n effic ien t presenter of :Jntiv;clI. 
MATER IALS ANn M ETHODS 
Cytokillcs and Rcagcnts .)'I"/Iily/oroi'm.,· , /1/1'( ' /1 ... Cowali' .<tra in I /SAC 
(I'allsn rhill) ! was ohl.ui ll cd frl) m C .. lhioc he lll (La Jo ll ". CAl: CG llI' w"s 
o btain ed n 'OHl Pe ninsu la Laborat.ories (\"k.h\\ol1t. CA): g,ranulol.;ytc-nl ac-
1'1)1'11:11;" co lollY stillllllal'illg I~ l c l or (CM-CSf:) IVas obtaillcd ti'olll Dr. S'l'VC 
C brk (Gc ll e tics '"sl itlil e. C:lIl1brid~l', MA); I L-~ waS purc /la sed li,.,111 
GC IIZY IIlC (C al1llwid!,';c, MA): IL- 13 was o htained ft'om Dr. AII IIC O'Garra 
(J)NAX): :lIlli-hllrnali IL- Ill ne ll tra li zillg antihody (anri- IL- IIl) was hnl\l 
R &' I) Sy .. tCIJI~ (MinlJeapoJis, MN): Gl, jatil) 21% \\Iel ,<) Pllfc!Jil ... ed fr() tll Sig 1l1:! 
(Sl. Lo ui s, MO) ; !"H!thYllIidillc (37 M hq) Was o hta illed li'o lll NEN Dupollt 
(Willlliligton , D E); and let:lllllS lox ,)id (TT) was purchased frol1l Con-
1I;J llgh t La'" (Sweetwater, PAl. 
Ptcpar"tion of Ccll PO~lulations Whole bll)od obl;) ill ed li'o lll 1I1l )'/1la! 
hca li'h y vo lullI ecrs waS diluled wi lh DI'IlS and ce illrifugcd 011 I~ ico ll ­
H ypaqll e (Pharlllacia, Pisca ta way. NJ ) for 311 lI1in at 500 X .~. T he illte rface 
c Olltain in g PBM C was \\lash ed w illI DPBS :Iud rcs tl sp ' lHied ;n Cl) lllpIcLC 
Illedilllll (RPM I 1('40/ IO')i, FUS, 2 mM g lu r:lI11ille. 1(10 ullirs pe lli ci llill pCI' 
1111, alld 1011 f1.~ streptolll ycill per 1111 ; G IIJCO, Gra ll d Islalld. NY). 
MOllocyres wen; el1riched by adhere nce to tiS ~ ll C t:u(tllrc fla sks coaled 
H jill 2'1" ~r l iltj1) al1d a \lt olo~(Ju:-, "c.nl1ll, I'l3MC at a t'O l\ccntratio ll 0'-
10-20 X 10(' cd ls pe r nil i1l : , vo lw))c of 1:1 .nl wcre p l;lced jn the Aa sk ;-IIl(\ 
illclihaled Il' r J (J lIIill a t 37°C . NOIwd hcrcl ll' cells were washed Fro II I die 
H",k with Mediulll IIJ<) «(; IIICO) warnlcd to 37°C. Ad he re llt ce lls were 
reJ1loved frolll the nask hy incubation Oil icc with \)I'I\S/ I \1 ,"M EDTA. 
Ad Jl ere ll c ce ll prcparatiOi ls wen' g reater Ihall 1)4')1" C )) I 'I w i,.h fewer tha,ll 
11 :A1 c n t ~u !\ iti vc..:. cclb as dClc nllill c d by flo'\'\' cytu lll cery. 
A llogencic Mixcd Lymphocyte Assays Respollder ce ll s wen: ClIl tlln:d 
ill c Ollll'lcr" III"di"llI \Vil h irr"dia lL'd / , ·17CS S(l llrce (.'000 rad) / alloge ll e ic 
Sl i\lILlI"tnr .. e ll s at a rali " uf 20; I (rcspo llder:., rillllllator) with o r witho ur 
CGIt!> ( I flO li t{ pCI' 1111 ) ill round-holtLHnedllli crolitcr pl"tcs (ur ,I d. During 
Ih e till,d III h oCcu ll'ure . prnliferali ve respo ll ses were rn C:" lll'ed b)' I.l HITdll 
iIlCOrp(I/·;lli()lI . In ,orll e cxpcrilllellrs. sfiJilulatl)r ce lls were trea ted lo r 2 h 
w ir" 111(1 IIg CGIl I' pCI' lid alolle, thell w;!s heel and irradiatc<l priOl' to 
add it io ll or rcs ponril.: f (:e ll s . III th ese c ultl1rt.! s CG It!' wns II() ( added d urin g 
the" d incubation as dcscrihed ah!>ve. 
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Gcneration of Dendritic APC frol11 Monocytcs Tn prndllce ce ll ~ 
w ith the a l1 tig:clI-p n.;sc ll t-in g activ ity or de ndri tic ('db.. \"/e adaprcd tlt~ 
proced ure of Sallusl:I> alld LlI lZavecchia (1,)<) 4). Bridl y. l\loll <Jcytes \Vcr" 
c lilrurcd fm 6 d w ith GM-CSF alOll e (S il II g per lid), GM- SF p lu" IL-.j 
(S ilO U Jl cr 1111 ). Or GM-CSF pillS IL- 13 (20 II I; pCI' lid ) ;1' .17 DC. F() J1 o\Vi " ~ 
cllitu re, ahlllldant levels or C I) 1 alld M H C C lass (I ;Ire eX)J rcssed Oil th"sc 
eel !.s. ""d C D I-I expressiolJ was .s ig llil·inlllil y dilJlilli ,sh l'C1 (Payan " lId Gol·tzl, 
I')tHi). 
Antigen-Specific P.·oli{'cr"tion Assays I'J.!L (2 X 10" cel ls PC[' 111/), 
derived fr01l 1 illdivid\1~' s ,!;\ccin,ltco wid, 'll 1'-1 d prio r. wen..' \: \I{tHre d 11) 
C()lI lple te JII cdilllll for <)-1-1 d ill th l! p rese ll ce o f TT ( I : IO .non vol/vo l) , 
Ahcr.'i d , thc cel!.s wcn: rc.,,.illllliated wilh TT ;lIld 11.-2 ( Ion U 1' 101'1111 ). O " c 
day prim 10 lISe ill prol ile rati o ll ;ISS;I),S, rh ' lII"di ulIl was re placed with ft·cs !] 
cOi ll p lete mediulII wirh nllt TT or IL-2. For assay. ce ll s were plated al a 20: I 
ratio of n : sponcicr to :1l1l:o lug-O ll S III OIl{)cytc-de ri ved <l lltigl' ll -prCSl'l liing-
de llclrit'ic ce il s ill a rotlllti-bnlt(lIll ecl Illicrotitcr pl' lte. Ce ll ~ were culrllred ill 
llI ed illlll :dll ll e, C GRY ,dnll e (10(1 II I; pcr ml), or CGIt!' pIllS TT 1',.\1' ·1 d or, 
a lt c rll a ti vc ly. llu') Jl ocy tc-dcri vcd :t llti g:C II - pn.;SCIlCill g dendrili c cd ls w~r~ 
ill l' lIhated fur 2 h wi. h Ill ed illlll a lo ll e, CG ill' a loll l!. or CG RI' p illS T1' 
followed by was hing, prior 10 addil'iOIl or respo lld illg cdls. COlIl:roh 
cO ll ta illillg o lll y TT were rUII ill paralle l. DlII'illg Ihe lilwl I H II "f c ul ture 
pro li ferative response" were m easured hy [.1 H1TdR in corporarioll . ' 
CytokillC Assays C<.: lI culI:ure supernatants 1,) 1' 11, - 10, I L- 12 p.IO , a llel 
I FN-,), prod ll crion .srudi e,s wel'e obl'ailh'd by ill cllha l:i llg PIIM C (2-5 X I \ll, 
cel ls pCI' 1111) w irh CGRP ( IO - IO() ng pe r 1111) ill the prescllce "" ahsell ce of 
SAC ( I: 10 ,0(0) fi" r 2'1 h at :I 7"C. In e"perilll e li ts e":lIl\illillg I L- 12 1'40 allel 
ll: N-y prodllction , IH, ulraliz illl; allti-IL- IO antibody (2S J.l.1; per Illl) wa, 
added at ("he initiation of nJlr-urc. A ltl'l"llilri vcl)'. 1l1 () ll ot.:yt"c-dcri\,cd de ndritic 
ce Us ( I X /(I " cell" pCI' lid) were cu lfll rcd wilh SAC alld CGRP ao d 
:-; \l pl! nl ~'tC\nls harvested as cic :\~ribcd ahoyc-. IL- 12 p -iO W:l!\ assayed in 
ce ll-free Sllpel'lJ:ltallt hy RIA 'IS previollsly descrihed Uakab .. , II I. 191)3). 
It- I II and IFN-y wcre as,,' yed II si llg ELISA (Elld()ge ll , IlI c . . U()SI:OIl, MA) 
;:\tTo rdil1 g to In anu r: tt:cu n :r \ xp t..!cifit.;a tio lls. T he .H.' JI .'i' ili v iry of .hese ;).<iisays 
was < 3 pg per 1111 alld S pg p cr 1111 fur IL-IO :\IId IFN -')', rcs pccrivc ly. 
F low Cytol11ctry PI.IM C were washed alld resuspe llded ill st;lillilll; bllll<:r 
(J)PUS/2'y" F13S ;llId 11 .11 2% NaN,). M o use "lIli-hulllall 1l7. 1 o r 137.2 
alii ibodics were inc llh:ltcd w ith the ce ll s Oil icc for 20 l11io fo ll o \vcd hv 
washi ll g and suhs<:que llt in CllhatiOIl w irh PhycoerYl'hrill (I'E)-Iabeh:d go:;r 
anti - Illo ll se Ig. T he ce ll s were was hed alld kepI ill 1'% paraf')l'IlIaldehydc 
lIlIIil analysis. 1.17 . 1 and Ll7 .2 I\l e;l ll challll e l llllOreSCl' lICl: levels (rela ti ve ce ll 
:\ lIrf;lCC density) OJ) the gal.ed Hl o n ocytc pop\llation wc.rc octcnnincd. 
P CR Analysi .• and Southern Blotting Cel ls c lJlJ-urcd as illdir :\ted Were 
Iwrves led, :llld (o(a l RNA W'IS e-, (,.;lcwd us in~ Trizo l (C IIJ CO llH .. L, 
C;:l i t h ershuq~, M U ) . R,NA was rcvcrseJ trallscribed usin g S liperscript Ii 
reve rse lral1~c ripLa se. and pe ll was pcrfnnllcd Oil a llifHhcnn \11 hiOc.yc1cr 
(r::l ir/' Il'. VA) wi l'iI ril e 1i) lJ uwillg profile: 94 °C for 4 llIi" (o ll e cycl e). 9-1°C 
I,) r 45 s. S5 "C f" r -15 s, ,\lId ?Z oC (0,. ')11 s (.10 cyd es). T il e I L- I () p"illlers used 
wen:: ro r"';I,<1. 5' -CAAGACCC/\ GAC/\ TCAAG-3 '; and reverse, 5 '_ 
AATAGAAATGGGGGTTGAG-:l'. T he PC ll pro dll Cl's were visuali zed Oil 
agaro,"ic gl.: l.'\ a nd lnlJtstclTed Lo Zcrahind J11 CJ1 lbr;lIll! (CUIlO Corp. Nh: ridi;lll. 
C T) for " ":ll ysis hy Southe rll blorlin ); . Ihie Hy. ~e l s we rC soaked ill 11.5 M 
NaOH/ I .5 M NaCI fill' 311 III in fo ll owed b y two 15 \l\in w:\S hes ill 0.5 M 
Tris-H C I. p H 7 .4, pillS I. S M Na C I). T he fi lter was prch ybridized ill 5 X 
SSC. 0.1 % SJ)S, lO X De llhardt's -,o luti OIl , alld 0.1 Ill g sa llllo ll sperm DNA 
Iwr Inl for I H " al~ 42°C and II )'bridizcd in .'i X SSC, 0.5% SDS, "lid 11 . 1 \1\ 1; 
sallll o ll ' perlll D NA pCI' 1111 fi) r 24 " at ·12°C cOl ltaillin g a ''' I'-c lld- Iahelcel 
lI es led o ligollucieotide probe lor IL- IO (S'-TATGTAGTTGATGAAGAT_ 
CTC-3'). T h e filt e r was washed ill 2 X SSC pillS n .1 % SDS :II: rO(1l ll 
IClllpCrattl re, [hell twin : :11 ·12°C , Ihell expo.<ed to Kodak XA Il-5 film fil l' 
2 '1 h :It - llO"C. 
Statistic;,l Analysis !Jaw s i gn il~i ca ll t:e alld p va lu es wcre determilled 
\I sing the Ma llil -W hirney ran k re s\. 
IU3SU LTS 
CGRP DownrcgulHtcs Prolifcl'ative Responscs of Human 
PBMC We exa min ed the abi lity of CG IU' to regulate alloal1ti-
gel/-ioduced prolil'C rari OIl . Purit-icd allogenei c m o nocyte, were 
c ul ture d with respond e r P13M C for 4 d in t h e cOlltinncd prese l1 C\! of 
CGRP (lOO n g per 1111) 0 1' a ltel'llatively. stilllulator ce ll s were 
in ctl hated for 2 h w it h CG R.P (1 0 0 ng per 1111) and t h e n washed 
pri o r to t h e ir add it io n to respond e r ce ll s, then in c ubarcd for an 
addi tion a l <I d, ,m d prolife ration was m eas ured b y lJ HITdll., in cor-
porati o n . Responder ce ll s c ultured in thc presen ce of stimulator 
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Figure 1, CGRP inhibits aJloantigen- and antigen-induced prolif-
erative responses of PUMC from normal individuals, (A) Sti1l1ul ato r 
PI3M C (11 = .1) were ",ashed with 1l1ediu1l1 alolle thell y-irradiated. T hese 
ce lls were added ro rC' I"".der cells at" ratio of 2n: I (sti1l1ulato r: respollder) 
and cultured ill mcdiu1l1 alolle (_) or with IIlO Ilg per 1111 CG ltP (~) for the 
rCI11a illill g 9() It or culture . Additi o llall y, still lula to r ce ll s we re incubated 
with 1011 Ilg CG It!' per 1111 Il'" 2 h prior to addition to respollders (CG lt !> 
pre-inc. ~) T hese sti1l1u lator ce lls we re then irrad iated, washed with 
med iu1l1 , alld cul tm ed with respollde rs for lJ6 h at .17 Q C. Pro li fe ra tioll of 
res I onder ce lls ill the ahse llce of sti1l1ulators arc also showll (0 ). Pro lifer-
ation was lll e'lS lII'ed hy illcorporatiOIl of l"HITdlt durillg the I'illal III h of 
culture. The data arc ex pressed as Illea ll Cpl11 2: SD. " , P = Il.OtH; ** , P = 
0.0006. (B) Puritied ",oll oeytes fro lll norlllal individuals boosted with TT 
vaccin e 14 d prior (11 = 2) were cultured with GM-CSF, GM-CSF/ I L--I, or 
GM -CSF/ IL- I:I for (, d alld lIsed as 1l1oll ocyte-deri ved dendri tic APC. PU L 
from the sa llle dUllors were incubated with l11 ediulll alone (0 ) or CG ltP 
( 100 ng per 1111 ) ,doll e (_) lor 2 h, lo llowed by washillg, T he)' were thell 
added to the APC ill the presence ofTT. III addition, PH L wcre se t up with 
APC plus TT cOllraill inl; CG ru) ( I 00 II !,: per ml) fo r the duratioll of culture 
(~). T he APC: lylllphoc)'te cullures were incuha ted ;11 37 Q C fo r 4 d and 
pulsed with 1.1 1-1 ITdR durillg the lillal I fj h oJ' iucubat:ioll ill order to lIIeasure 
pro li fe ratio n . T ill.' ,bra arc cx prc!\scd as rll l';t n CO lillfS pc r Ill i l1 :±: sn. 
Cu l tLln.!.~ rece iv illg TT alo ll L' w irho lll' A Pe iwd pro li fcra t'ivc respo ll ses of 
8 I 56 Cp lll . * , P < 0.1l I COlli pared to n llrures reCl:ivill !,: lI. eci iulII alonc, 
ce ll s w ith o u t CC RP demo nstra ted signifi ca n t pro li fe ration (8534 ::t: 
1 146 cpm) (F ig 1A), When CC R» was present li'om the ini tiari o n 
o f c u ltu re , a sib"lifican l' decrease of 47')1" in pro li fe rati ve response 
was o bserved (8534 ::t: 11 46 I'S, 5()42 ::t: 1023 . P = 0.0(4), 
In te restin g ly, w he n stimu lato r ce lls Were in cubated with CG ltP for 
2 h fo ll owed by washin g befo re add itio n to respondc r cell s, the 
CG I'l...P-induced inhibi tio n of a ll oa n tigen pro lite ra tio n wa s approx-
imately 2- fo ld g rearer (H 5%) (8534 ::t: I 146 liS , 26(L ::t: SO I . I' = 
O,O()()(» th an the inhibi tio n obse rved in cultures without CC ltP 
pre-incu bati o n . P13M C pro li te rati ve respo llSes in response to exog-
e n o u s IL-2 do not appea r to he signi fi ca ntl y inhibi ted b y CC R!> 
(data not sho wn). T hese findin gs suggest that the inh ibi tio n 
induced b y CC RI' co uld be .m ed ia ted by a direc t effeet o n the 
m o n ocyte sti mula tor po pul;lti o n , 
To determin e w hethe r CG RP could :l lte r reca ll antige n-d ri ven 
pro liferative responses. we cul tured P13L fi'o l1l lI o rm al do no rs 
vaccinated w ith tetanu s toxo id (TT) in the presence of competent 
a utol ogo us APC plu s TT. T he resu lts fi'o l11 a re presen ta tive don o r 
are shown in F ig lB, W hen I'13L were c ul tured togethe r w ith 
monocyte-derived dendritic APC witho ut CC R.P. the l'e was a 
unifo rml y v igo ro us pro li fe rative respon se (22.5 ()()-27. 00() cpm) to 
TT. In th e prese nCe of 100 n g CC RP per 1111. howeve r, a decrease 
in pro li feratio n ( 18-43%) was observed in all c ultures tested, The 
d ecrease was statist ica ll y signifi can t (p < (Ul l ) in five of the six 
co n d itions receivin g CC R.P. T his inhibi tio n w as o bserved w herher 
APC wcre p retreated for 2 h with CO RP o r w hether CG RP was 
ad ded w he n respo nd in g lymph ocytes wel'e combined with APC. 
CGRP Downregulates Expression of B7.2 The data pre-
sentcd in Fig l A ,B sugges t tha t CGRI' m ay inhihit certain immu-
nologic respo nses by ac ting direc tly o n APC populations. To 
d etermine the e !lects o f CC RP o n monocyte exp ress ion of co-
stimu latory m o lec ul es. w e exam in ed its abi li ty to alte r th e leve ls of 
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Table I. Expression of B 7. 1 and B7.2 on Normal 
Peripheral Blood Monocytes is Decreased in Response to 
Calci ton in Gene-Related Peptide" 
C lli ture 




CG rU' + anti- IL-J(I 
allti- I L- I 0 




CG It» + al1ti - IL-lll 
anti- IL- I II 
Mea" Chall nel Fluorescellce (MCF) 
Control 137. 1 137.2 
-
------
III I I 9-1 
I I II 0,7 
U II 77 
10 -12 175 
IX 2(, 160 
III N.D." 532 
I I N.J). 239 
13 N.D. 33.3 
In N.D. 7~ 1 
18 N.D . 7 18 
---------
,I Periphera l hlood t1l (lIHH·y t C~ we re c liri dlL'd hy :l.lll ll:.rclll"l' 10 gchllill cO;lI l:d fla ~ks 
and c lIltllrL' c! in tlte illlJi COlll'd rt':1~C III S fnr 24 h . Cl, lI s wcrt' s l:1il1t..'d wi th :lll li- U7. 1 
(C DSO) n l' a lll i U7.2 (CDK()) II s"-ill g indirect illl1lHIIll)f\1l0rCsccll cc. Plt ycncrrrhrill -
c01~itl galcd goa t ;'t 1l 1'i-1I10IlSl' 19 "';'I S used :1:. ~l'("n lld Ah a nd ~cn'cd as cOIHrlll ill th e 
ahsc ll cl' tli" prilllary Ah . M er w:\!\ dl'tt..'nllilll..'d Wili ng ;l FAC~c;lI1 Il ow C)'ttlllll' ll'r . 
" N. D .. Ilot ch","cl"ltlil1 l'd 
137,1 (CDsn) ~nd 137 ,2 (CD86), Puritled m o noc)'tes we rc cultured 
in m edium alonc , CC RP alo ne ( l Ot) ng pCI' ml ). IL-IO a lone (l ng 
pCI' ml) , anti-I L- I n a lon e ( 1 () }J-g pCI' 1ll1) o r CC RP plu s :lII ti- IL- l n 
te l' 24 h and then exa m in cd by flow cy tometry fO r expressio n of 
13 7. 1 and 137,2, T he res ul ts 6'0111 two expe rim ents arc p resen ted in 
Table L M o n ocytes cultured in lIIediun. alo ll e de lll onstrate low 
le vels of 13 7. 1 and signi fican tl y hig he r levels of 137.2, In the 
presen ce o f CC RY alon e ( 100 ng pCI' ml ) , a signiti ca nt decrease in 
137.2 (9-1 I'S 77 ~ nd 53 2 "s 33,) m ean ch:II1I1l:1 rluorescen ce was 
detected . reflecli ng a decrease in the su rfilcc density of 87.2. 
wh e l'eas th e level s of 13 7, I remained unchanged . Addition of 
exogen o us I L- I 0, a potent inhibitor of m ac rop hage fun ction, at a 
conce lltra tion o f I n g pe r mi. elici fcd a silllilar patte rn of 87. 2 
redu ctio n , 
To in vestigate w hether ind uctio n of IL-I () by CCltP m ay 
repre$ent a possib le m ech anisl1l responsible fo r the regul ation of 
137 .2 expression. periphera l hl ood m onocytes were cul tured in 
CC R.P w ith and with o ut neu traliz in g an tibodies to 1 L-I n, Addition 
o f anti- IL- l () sil1lul ta neous ly with CCRP to cultured m o nocytes 
compl e te ly revc rsed the CCR!> in duced-inhihi tion 01"137.2 expres-
sion o b served in cultllres w ith CCR!' alo ne, Furthe rlll o re , addition 
of an ti- I L- I (I to cul tures contai nin g CC ltP elevated le vels of 137, 2 
~xpress i o ll ;1bovc those fo und \vith 11lcdi lll11 alone. suggesting the 
toni c presen ce oflow levels of IL- I 0 that m ay norm all y downrcgu-
la te 137.2 ex press ion . T he addi tion of anti- IL- IO alone to 111 0 no -
cytes co ntlrlll ed that neu tra liz able lL- 1 () is p resen t in fhese cultures 
(Table I) , 
A ugmentation of IL-t 0 Production b y CGRP To further 
e lu c idate w hether CG RY ca n inhi bit prolitCr:1tive responses 
thro u gh the in d uction of th e inhibi tory cytokinl', I L- I O-puri tled 
1II0 nocytes w c re cultlll'ed in m edium alo ne . SAC a lo ne. or SAC 
a lo ne pl us CG RP fo r 24 h , and the supernatants fl'om th ese cul tures 
were anal yze d fo r IL-1U usill g an IL- IO-specitlc ELISA . The data 
fi'o lll a re p" esclltat ive ex peri lllent arc depicted in Fig 2. Mon ocytes 
cu ltured ill lII ed ium al one produce low levels of I L- I 0 hue, w h en 
cul tured in SAC, the produ c tion of I L- IO in creases m o rc thall 
IO- to ld ( I ,,-' 13 pg pe r ml). W hen CG lt!' is added with SAC. the 
level of I L- I () proteill secreted is illcre;[sed lI1 0 re than 2-fold (1.1 !'.' 
30 pg per ml) w he ll compared with that induced by SAC a lo ne, 
C ultures tlw t received o nl y l1I edium plus CG RP d id not show allY 
in c rease in IL- I 0 prod uction over m ediul1l alo ll e (data not sh owlI). 
T he illSet to F ig 2 indi cates that the illcrease in IL- I n proteill is 
<Icco lllp;lIIi ed by <1 11 in creased express io ll of I L-I () t1l RN A, T hese 
data su ggest tha t CC I'l...P ca ll lIpregulate I L- I (I ill SAC-acri\,ated 
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Figure 2_ IL-t 0 production is augmented in SAC- activated PBMC 
treated with CGRP. PUM C (n = 5) were cultured for 24 h at 37°C in 
completc mcdium alone }, mcdium contain in !; SAC alone ('I: I O.OUO; ~). 
or ' AC pillS CG RI' (.) . C ulture sIIperna ta nts were assayed for IL-I U 
content by ELI SA. IL- IO lcvels arc expressed as mean p!; per ml :':: SI) . 
(inset) Total RNA was ex tracted frorn thesc P13M C lI sill!; T ri zo l. and IL-I 0 
I11RN A was amplificd using fl. T-PC R. Levels or IL-I (I -spccific amp li fi ed 
seque nces 'we re visualized Ll sing EtBr staining; and con finned lI sin g an 
IL-I O-specill c II cs ted oligonucl eo tide probc hy SOllthcl'll blottin g. 
ce lls w hi h. in tUl'll , m ay ac t to inhibit prolife rat io n and antigen 
presentatio n . M onocyte-deri ved dc ndritic APCs showcd a similar 
ability to upreg u latc I L- l 0 ex press ion in rcspo nse to CG LU). As 
show n in Fig 3 , increases in I L-l 0 produ ction in culturcs of 
cytokin c-indu ced APCs rcceiving SA C p lus C GR.P werc 2- to 
3-fo ld grea tc r th an in thosc cul turcs receivin g SA C a lo nc. 
CGRP Decreases IL-12 and IFN-y Production by PBMC 
Sin cc IL- l0 ha s bce n dc mon str,Hcd to an tagon ize the ac tiv ity of 
I L-1 2 and I L- '12 is a potcnt indu ccr of I FN-y, we so ught to 
d e te rm in c whe th e r C GRY was actin g to a lte r the leve ls of lL-1 2 
and IFN-y pro du ced by p13M C . PI3M C were cultured for 48 h in 
e it he r comple te medium or SA C containing CG R.P alone, anti-
lL-I () n e utra li z in g antibod y, or CG R!> p lu s anti-IL- l0 from the 
ini tia tion o f culture. C GR.P al one cou ld sig nifi cantly inhibit the 
abili ty o f PI3M C to pro du ce IL-1 2 p4() in respo nse to activati on 
wi th SAC (Fig 4A) a t concentrati on s as low as I ng pCI' 1111 (66'1." 
P = D.003). As shown in Fig 4B, SA C - stimulated ce ll s culturcd in 
th e prese nce o f CGRY a lone demon strated ;1 signifi cant decrease 
(34'Yr" p = 0 .(1 3) in IL- '12 p40 pro duc tion as compared to cultures 
recciving S AC alone. The reduc tion in I L-1 2 p4() pro duction cou ld 
be re ve rsed to control leve ls in t he presen ce of neutralizin g 
anti- IL- l 0 antibodi c s, suggestin g that the decrease in IL-1 2 p40 is 
du c to IL- IO . A sma ll but si gnifi can t dccreasc in IL-1 2 p40 can b e 
o bse rved in ce lls cul tured without SA C. T hi s decrease is also 
abrogated in th e presence of anti-IL- I O. MOll ocyte-de l-ived den-
dritic A PCs cultured ill SA C plu s CGRP also demon strate de-
c reased I L- '12 1'40 produ c ti o n co mpared to cul tures in cubated with 
S AC al on e (Fig SA). 
B eca use I L- I 2 is an indu cer o f I FN-y we in vestigatc d the e lt'ect 
of CG RP 0 11 the regulation of IFN- y produ ction. Cells cultured 
with SAC plu s C GR.P dClllonstra ted a sig nifi cant decreasc of 
approx imate ly 30% (I' = 0 .( 27) in IFN-y produ c tion cOl1lp'lred to 
ce ll s in cubated in S AC a lo ne (Fig SB) . In terestingly. allti- IL- l () 
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Figure 3 . CGRP augmcnts IL-IO production by SAC-activated 
monocytcs. PlIrif, ed monocytes fro ll1 1I0rmal indi viduals (n = -I) were 
cultured with CM-CS F. GM-CS F/ IL-4, or GM CS F/ IL-1 3 in completc 
nlCdillTl1 fo r G d . The Illonocytcs w e re w;lshed and then inc uba ted \-\lith 
mcdiull1 alonc (O ). 100 ng CCRY pCI'll'l l alo lle (~). I: 10,000 (vol/ vo l) SAC 
alolle (_) . or SAC plus CC ll.P (~) for all additional 24 h. C ulture 
supcrna tall ts wcre assayed for I L- I ° COli tent by e LI SA. I L- IIJ Icvels arc 
expressed as pico!lrams pCI' ml :':: SI) . 
t io n as it did with IL-1 2 p40 produ ction . These data sugges t that thc 
inhibi ri o n of IFN-y by C GRY ma y be on ly partially due to th e 
pro du ctio n of IL-l0 and furth e r impl y rh e presence of othcr 
C GRP-induced factors that ,Ire capable of blocking IFN-y produc-
ti o n . 
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No Tx CGRP a nli · CG RPI 
IL-10 a nli · IL-10 
Figure 4. IL-12 1'40 production by PBMC is inhibited by CGRP. (AJ 
Purified PBM C from a representa tive donor werc cultured with SA C "Iollc 
(I : 10,000 vo l/ v o l) or in the presence of 0.0 I , 0. 1, 1.0. or 10.0 n!; CG R .. P per 
1111 fo r 24 h at 37°C. Cul ture supernatants were coll ected asepticall )' alld 
assayed lo r IL-1 2 p40 protein. IL-12 p40 level s arc expressed as picogralll s 
per 1111 :<:: SD. *, p = n.0004; ** . p = O'(H102. (8) Purified P13M C from 
normal indi viduals (n = 4) were placed in either mcdium alollc (O ) or 
IlIcdiutll containing SAC ( I: IO.noo; _) . To each of lhcse culturcs either 
IlIcdiulll alolle, 100 ng CGR.P pcr 1111 alollc . 25 ILg; ;\IIti-l L- I 0 pCI' 11'1 alOllc. 
or eCrU) plus anti- IL-l () was added and the ce lls were incubated for 24 h 
at J7°C. Cul turc supernatants were coll cc ted asepticall )' and '" sayed for 
I L- l 2 p40 contcnt by hioass,'y. I L- '12 1'40 levcls arc cxpresscd as picog;rams 
pCI' 11'11 :':: SD. *, p = (l .01 3 
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No Tx eGRP anI!· CGRPI 
Il-IO onU·IL-10 
Figure 5. IL-12 p40 production i.s inhibited i.n SAC- activated 
nlonocytcs treated w i th CGRP. (A) Purilied monocytes from Ilorma l 
ind ivid ual s (n = 3) were culturcd with GM-CSF. GM-C SF/ IL-4 . o r GM 
CS F/ I L- 13 ill complcte mediulll for (, d. T he ce lls were the ll ill cubated with 
m edium alonc (0 ) . 100 ng C GR.P per ml alo ne (~) . I: I O.DOO (vo ll vol) SAC 
a lo ne (_). or SAC plus C GR.P (~) for all additional 24 h. C ulture 
supernatants were assayed for IL-12 p40 con tc nt by bioassay. IL-1 2 p40 
levels arc ex pressed as picogralll s per ml ± SI). (13) IFN-y production by 
SAC-activated I'BM C treated w ith CG R.P . Puril'ied PUM C fro m norn",1 
individuals (11 = 3) werc cultured ill e ither medium alone (0 ) or SAC 
("1:10.000; _). To each o fthesc culture conditions eithe r medium alo lle. 1 ()O 
ng ccru' pCI' m l alone. anti-IL- IO. o r 'C lU' plus allti- IL- IO was added . 
and the cell s wcrc ill cuba ted fo r 24 h at 3 rc. C ulture "'perll atallts wc re 
assayed for IFN-y content by ELISA. IFN-y levels arc expressed as 
picogralll s pCI' ml ± SI). *. p = 0.027 . 
D ISCUSS ION 
In this paper we describe the abi li ty of the Ileuropeptide CGRP to 
ac t as an illlllll in oregu latory factor. We confirm previous observa-
tions made usin g ani mal mod e ls and extend these to the human 
syste m , w hi ch indicate that CG RP can act as a potent inhi bitor of 
J11itogen and antigen-induced proli ferative responses of human 
PBMC (Fig tA,B) and appears to exert its e ftects, at" least in part. 
by inhibition of antigen presen tation. Our findi ngs indicate that 
CGIU) can augment the level of IL-11l protein produced by 
ac tivated mon ocytes ina smu ch as detecta b le levels of IL-l 0 can be 
found in cu ltures of PBMC and monocytes after in cubation with 
CGR.P (Figs 2.3). In addition. IlI RNA for IL-IO is upregulated ill 
cultures receiving SAC plu s CGRP w hen compared to levels ill 
cultures receiving SAC alone , indicatin g that the in crease in IL- IO 
production is due to C GRP indu cin g the synthesis of I L- I 0 (Fig 2. 
inset). The addition of neutraliz in g antibodies to 1 L-I 0 can b lock 
the CG RP- indu ced inhibition of I L-12 p40 fi'om SAC-treated 
monocytes (Fig 4B) and . fll1a ll y, decreases in the cell surfil ce 
expression o f £7.2 o bse rved in the presence of CG RP can be 
abrogated by the add ition of anti-I L- I () (Table I) . Interestin gly. we 
have on ly observed CG RP-in du ced au gm entatio n of! L- I 0 produc-
tion in activated ce ll s. T his su ggests that responsi veness to CG RI' 
ma y be mediated by indu ction of specif'i c recepto rs. C e ll surf.1Ce 
receptors for CGRP have been described (Abell o l'I al, I ,)91; 
McGi llis c( ai, 19')1; Vignery ('( al, I ,)9 1; McG illis c( al. "1 993). 
Numbers of low aftin ity receprors (2(),OOO sites per cell) present o n 
muri ne 70Z/3 pre-B lymphocytes were not found to change upo n 
trea tment w ith li popolysaccharide w hereas the number of hi gh-
affi nity recepto rs increased 4-fold (10 5 sites per ce ll to 405 sites per 
ce ll ) following lipopolysaccharide treatmen t (M cGi llis ('( ai, 1993 ). 
Low numbers of high-aftin ity receptor sites « I OO() sites per ce ll ) 
have also been described on rat lymphocytes (M cG illi s c ( al. 199 1). 
The actions of IL-'I () ha ve ;lII tagonisri c or inhi bitory clfects on 
sevel'al cytokines, including I L-12. which is prod uced by activated 
lymphocytes and 1110nocytes (D' Andrea ct (/1, 1992). T his ma y 
exp laiJ1. in part, the potent anti-pro li ferative activ ity that CGRP 
can exer t o n lymphocyte responses . I L- '12 and the 137 /C D 28 
co-stim ul atory pathway synergize to increase proli feration and 
cytokine pmduction by T cells (Kubin c( ai , 1994). lL-"12 is 
produced ~s ~ biolog ica ll y active heterodillJer (p70) that is COIII-
prised of a p35 and p40 subunit . Like the biologicall y ;Ictive 
heterodimer, the p41l subunit is indu cible by a variety of stimu li in 
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those cell s that make the activ e p70 m o lecul e. T hi s makes p40 a 
convenient m eans of estimatin g the amount of active IL-12. Our 
data indi cate that CGRP ca n indu ce IL- to produ ction by P13M C or 
m onocytes , and this in creased lL-J 0 ca n result in a decrease in both 
the le vels of I L-12 produced and the levels of 137 .2 expression on 
the APC su rfa ce . The concomitant decrease in both I L-12 and 137 
docs in deed inhibit the proliferative response to anti genic stimu la-
tion (Fig tB). In terestingly. in those expel'iments examining allo-
geneic mi:-.: ed lymp hocyte responses (Fig lA), w hen stim ula tor 
ce ll s we re in cubated tirst w ith CGRP for 2 h . washed. then added 
to responder ce ll s, a greater inhibi tio n in proliferative responses was 
o bserved w hen compared to responses of cultures receiving CGRP 
only during the incubatio n with responder ce ll s. T his suggests that 
CG RP ma ), be exerting a direct e ffect on th e stimulator cells. Since 
o ur data indica te that IL-l 0 is not induced by CG RP in unstimu-
lated cell s (Figs 2.3) the decrea sed proliferation in mixed lympho-
cyte culture might be attrihutable to a decrease in 137 expression 
alo ne. This is supported by the observations that, in unstimulated 
norma l b lood mo nocytes. CGRP can downregulate ex isting levels 
of 137 (Table I) . It should be noted that th e low levels of 
neutralizable lL-IO seen in some of these cul tures may also be 
contributin g to the in creased inhibition observed in the cultures 
pre-incubated with CG R .. P. 
T he ability of CG ru> to induce IL-I O and downrcgulate B7.2 
ex pression ma y have important impli cations on the development o f 
a T helpe r 1 (Thl. he lp for a cell-hased immune response) II/T.WS a 
1" he lper 2 (Th 2, he lp for a humoral-based immune respollSe) 
respolISe. Recentl y. Kl.lchroo 1'( al (1995) demonstrated a correla-
tion between B7 e :-.:press io n and development of T hl o r Th2 
response . Usin g nlurinl: experimen ta l all ergic encephalomyelitis, a 
di so rder attribu table to the inducti o n of au to reactive Th l cells. 
Ku chroo fo und that antibodies aga in st 13 7 . I redu ced the severit), o~ 
the disease wherea s alltibodi es aga inst B7 .2 in creased tlIC severity of 
the disease. T hey suggest that the intera ction of 137 . .1 with the 
appropriate counter receptors on T cells (CD28 and CTLA4) can 
preferentia ll y ac t as a costillluiator for the gen e ration ofThl T cell s 
whereas 137 .2 co- stimulates and indu ces T h2 cell s. Freeman ct al 
(1995) ha ve shown that blockade of all ogeneic mixed lymph ocyte 
reactio n \Isin g antibodies to 13 7.2 redu ces the levels of borh IL-2 
(Thl) and IL-4 (Th2) mRN A. whereas antibodies to 13 7 .1 sele~­
tivcly red uce IL-2 but nor IL-4 mRNA. Given that in creases III 
IL-IO levels and decreases in IL-1 2 and lFN-1' levels occur in 
response to CG R.P treatm ent and that CG RP can alter the ratio of 
137.1:137.2 'xpressio n on APC. it is apparent that CGRP plays an 
importa nt role in the generation of a T hl o r T h2 response. We :lre 
currentl y investigatin g the imlJlun e respo nse pheno rype resultll1 g 
fi'om CG RP treatm ent. 
We ha ve described our o bservati ons o n th e role of the ne uro pep-
tide CG RP in alterin<T immune-mediated responses ;/1 1'; /ro. These 
o bservatiollS contribl~e to the ·xpanding base of in formatio n that 
suggests ~I close rebtionship between the nervOus and immune 
systems. What is ye t to be dete rmin ed is the irnlllunoreg ul atory ro le 
of CG R..P ;/1 1'i ,},) and the ro le that the neuronal compo nen t of thIS 
system plays in inducing an immunosuppressive state . 
-I'h ; ... If 'c "'/': 11'(1": .wjJport rd "r (I DcrlllfH%J!Y FOlllulnti()1I rt'."l'tlI"(/1 .1.! 1'allt (l-~Er-),t1I1(1 
N nri",,,,1 I IISlilll/ 1' 4 H,,"/liI Grn lll.' ROI AR-I 2429 (ROC). e el 20S3} . 
C. c1 .12898, A I 3-1-1 12 (G T) . flllIl [WI C.c1588-1/ (rlH R). 
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